Literature DB >> 22618586

Regional reduction in gray and white matter volume in brains of cirrhotic patients: voxel-based analysis of MRI.

Motoh Iwasa1, Rumi Mifuji-Moroka, Makoto Kuroda, Hideo Moroka, Naoki Fujita, Yoshinao Kobayashi, Yukihiko Adachi, Esteban C Gabazza, Hiroshi Matsuda, Yoshiyuki Takei.   

Abstract

Chronic hepatic encephalopathy is a characteristically reversible neuropsychiatric disorder that occurs mainly in patients with liver cirrhosis. The brain regions critically involved in the pathophysiology of cirrhosis are not clear. Magnetic resonance imaging (MRI) with voxel-based morphometry (VBM) is a valuable tool for evaluating structural brain changes in many neurodegenerative diseases. We performed an MRI scan on 18 patients with liver cirrhosis and 16 age-matched healthy controls. We evaluated brain regional structural changes, regional differences and the relationship of these changes with the blood levels of ammonia and the results of neuropsychological tests in patients with cirrhosis. The VBM showed reduction in the volume of gray matter in the cerebellum and occipital lobe and in the volume of white matter in the cingulate, parietal, temporal, occipital lobe and precentral area in cirrhotic patients compared with controls. There were significant correlations between the volume of these regions with the plasma levels of ammonia and the results of neuropsychological tests. Voxel-based analysis of MRI revealed evidence for structural abnormalities of brain in patients with cirrhosis. Abnormal function in the above regions may account for the ammonia-mediated changes and neuropsychological deficits in hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22618586     DOI: 10.1007/s11011-012-9314-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  28 in total

1.  Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis.

Authors:  Björn Ahl; Karin Weissenborn; Jörg van den Hoff; Daniela Fischer-Wasels; Herbert Köstler; Hartmut Hecker; Wolfgang Burchert
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

Review 2.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

3.  Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.

Authors:  Ryosuke Sugimoto; Motoh Iwasa; Masayuki Maeda; Naohito Urawa; Hideaki Tanaka; Naoki Fujita; Yoshinao Kobayashi; Kan Takeda; Masahiko Kaito; Yoshiyuki Takei
Journal:  Am J Gastroenterol       Date:  2008-05-28       Impact factor: 10.864

Review 4.  Astroglial dysfunction in hepatic encephalopathy.

Authors:  M D Norenberg
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

5.  Attention deficits in minimal hepatic encephalopathy.

Authors:  K Weissenborn; S Heidenreich; J Ennen; N Rückert; H Hecker
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

6.  Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.

Authors:  Mónica Guevara; María E Baccaro; Beatriz Gómez-Ansón; Giovanni Frisoni; Cristina Testa; Aldo Torre; José Luis Molinuevo; Lorena Rami; Gustavo Pereira; Eva Urtasun Sotil; Joan Córdoba; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2010-12-14       Impact factor: 25.083

7.  Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry.

Authors:  Gail Musen; In Kyoon Lyoo; Caitlin R Sparks; Katie Weinger; Jaeuk Hwang; Christopher M Ryan; David C Jimerson; John Hennen; Perry F Renshaw; Alan M Jacobson
Journal:  Diabetes       Date:  2006-02       Impact factor: 9.461

8.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

9.  Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients.

Authors:  Federica Moscucci; Silvia Nardelli; Ilaria Pentassuglio; Chiara Pasquale; Lorenzo Ridola; Manuela Merli; Oliviero Riggio
Journal:  Liver Int       Date:  2011-08-15       Impact factor: 5.828

10.  Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese.

Authors:  Akinobu Kato; Motoichiro Kato; Hiromasa Ishii; Yosuke Ichimiya; Kazuyuki Suzuki; Hironaka Kawasaki; Shin-Ichiro Yamamoto; Ryukichi Kumashiro; Kyosuke Yamamoto; Naohiro Kawamura; Naoaki Hayashi; Shohei Matsuzaki; Akira Terano; Kiwamu Okita; Akiharu Watanabe
Journal:  Hepatol Res       Date:  2004-10       Impact factor: 4.288

View more
  17 in total

Review 1.  Multimodal MR imaging in hepatic encephalopathy: state of the art.

Authors:  Xiao Dong Zhang; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2018-01-26       Impact factor: 3.584

2.  Grey and white matter abnormalities in minimal hepatic encephalopathy: a study combining voxel-based morphometry and tract-based spatial statistics.

Authors:  Rongfeng Qi; Long Jiang Zhang; Jianhui Zhong; Tong Zhu; Zhiqiang Zhang; Chuanjian Xu; Gang Zheng; Guang Ming Lu
Journal:  Eur Radiol       Date:  2013-07-10       Impact factor: 5.315

Review 3.  Magnetic resonance of the brain in chronic and acute liver failure.

Authors:  Laia Chavarria; Juan Cordoba
Journal:  Metab Brain Dis       Date:  2013-11-21       Impact factor: 3.584

4.  Atypical neuroimaging findings in patients with acquired hepatocerebral degeneration.

Authors:  Xiaoyu Dong; Jianfei Nao
Journal:  Neurol Sci       Date:  2019-09-07       Impact factor: 3.307

5.  Brain Structural Changes in Patients with Pulmonary Arterial Hypertension.

Authors:  Bhaswati Roy; Susana Vacas; Luke Ehlert; Kathy McCloy; Rajan Saggar; Rajesh Kumar
Journal:  J Neuroimaging       Date:  2021-02-09       Impact factor: 2.486

6.  Anomalous gray matter structural networks in patients with hepatitis B virus-related cirrhosis without overt hepatic encephalopathy.

Authors:  Xiao-Fei Lv; Kai Liu; Ying-Wei Qiu; Pei-Qiang Cai; Jing Li; Gui-Hua Jiang; Yan-Jia Deng; Xue-Lin Zhang; Pei-Hong Wu; Chuan-Miao Xie; Ge Wen
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

7.  Cortical signature of patients with HBV-related cirrhosis without overt hepatic encephalopathy: a morphometric analysis.

Authors:  Xiu Wu; Xiao-Fei Lv; Yu-Ling Zhang; Hua-Wang Wu; Pei-Qiang Cai; Ying-Wei Qiu; Xue-Lin Zhang; Gui-Hua Jiang
Journal:  Front Neuroanat       Date:  2015-06-08       Impact factor: 3.856

8.  Diabetes Mellitus is Associated with More Severe Brain Spontaneous Activity Impairment and Gray Matter Loss in Patients with Cirrhosis.

Authors:  Yun Fei Wang; Xiang Kong; Guang Ming Lu; Long Jiang Zhang
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

Review 9.  The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

Authors:  Natalie M Zahr
Journal:  Front Aging Neurosci       Date:  2018-03-22       Impact factor: 5.750

10.  Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology.

Authors:  Santosh K Yadav; Rakesh K Gupta; Vivek A Saraswat; Murali Rangan; Michael A Thomas; Sergio Rutella; Silvio Danese; Ena Wang; Francesco M Marincola; Mohammad Haris
Journal:  J Transl Med       Date:  2015-10-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.